Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been rated between 2 and 5 on a scale doctors use to measure leg circulation problems (called the Rutherford classification)
- You are willing to attend follow-up check-ups at the required times after the procedure
- You are older than 18 years of age
- You understand what the procedure involves and are willing to sign a consent form before joining the study
- Your doctors expect you to live for at least 24 months
- Before joining, doctors have already been able to pass a thin wire through the blocked or narrowed area being treated
- The narrowed or blocked section of the artery being treated is at least 150mm long, as measured by an imaging test
- The artery in your upper or lower thigh/knee area (femoropopliteal artery) is either more than 50% narrowed or completely blocked
- Imaging shows that the artery just below the knee and at least one blood vessel leading to the foot are still open
Who may not be able to join:
- You have previously had bypass surgery or a stent placed in the artery being treated
- You have a fresh blood clot present in the artery being treated
- You have a known allergy or medical reason to avoid certain materials or medicines, including Nitinol-titanium (a metal used in medical devices), blood-thinning medications, or clot-dissolving medications
- You are pregnant or are a woman who could potentially become pregnant
- Certain additional tools (such as devices to remove clots or clear blockages using laser) are needed during your procedure
- You have a significant narrowing or blockage (more than 50%) in the pelvic arteries on the same side as the artery being treated that has not yet been addressed
- You are currently taking part in another clinical trial that has not yet completed its main phase
- You have significant kidney problems (confirm with trial site)
- You have a known allergy to the dye used in imaging scans (contrast media)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Meng Ye, M.D., Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University
Phone: +8615801900772
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary patency; Freedom of major adverse events (MAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.